Clinical Trials · NCT01709110

VERtebral Fracture Treatment Comparisons in Osteoporotic Women

CompletedPhase 4Teriparatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
1,366
Start date
Oct 2012
Locations
103 sites, 15 countries
Primary endpoint
Proportion of Participants With New Vertebral Fractures
View Teriparatide compound reference